Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

Andrea Harrer; H Tumani; S Niendorf; F Lauda; C Geis; A Weishaupt; C Kleinschnitz; S Rauer; J Kuhle; M Stangel; F Weber; M Uhr; M Linnebank; B Wildemann; S Jarius; M Guger; I Ayzenberg; A Chan; U Zettl; H Wiendl; Georg Pilz; Wolfgang Hitzl; J R Weber; Jörg Kraus

doi:10.1177/1352458512463483

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

Andrea Harrer^* (First author), H Tumani, S Niendorf, F Lauda, C Geis, A Weishaupt, C Kleinschnitz, S Rauer, J Kuhle, M Stangel, F Weber, M Uhr, M Linnebank, B Wildemann, S Jarius, M Guger, I Ayzenberg, A Chan, U Zettl, H WiendlGeorg Pilz (Co-author), Wolfgang Hitzl (Co-author), J R Weber, Jörg Kraus (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

60 Citations (Web of Science)

Original language	English
Pages (from-to)	1209-1212
Journal	MULTIPLE SCLEROSIS
Volume	19
Issue number	9
DOIs	https://doi.org/10.1177/1352458512463483
Publication status	Published - 2013

Keywords

MULTIPLE-SCLEROSIS PATIENTS
NEUROLOGICAL DISEASES
BLOOD
CSF

Access to Document

10.1177/1352458512463483

Cite this

Harrer, A., Tumani, H., Niendorf, S., Lauda, F., Geis, C., Weishaupt, A., Kleinschnitz, C., Rauer, S., Kuhle, J., Stangel, M., Weber, F., Uhr, M., Linnebank, M., Wildemann, B., Jarius, S., Guger, M., Ayzenberg, I., Chan, A., Zettl, U., ... Kraus, J. (2013). Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. MULTIPLE SCLEROSIS , 19(9), 1209-1212. https://doi.org/10.1177/1352458512463483

Harrer, Andrea ; Tumani, H ; Niendorf, S et al. / Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. In: MULTIPLE SCLEROSIS 2013 ; Vol. 19, No. 9. pp. 1209-1212.

@article{747b5dda071d48419a54cade7c43dbf2,

title = "Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.",

keywords = "MULTIPLE-SCLEROSIS PATIENTS, NEUROLOGICAL DISEASES, BLOOD, CSF",

author = "Andrea Harrer and H Tumani and S Niendorf and F Lauda and C Geis and A Weishaupt and C Kleinschnitz and S Rauer and J Kuhle and M Stangel and F Weber and M Uhr and M Linnebank and B Wildemann and S Jarius and M Guger and I Ayzenberg and A Chan and U Zettl and H Wiendl and Georg Pilz and Wolfgang Hitzl and Weber, {J R} and J{\"o}rg Kraus",

note = " A Harrer1 H Tumani2 S Niendorf2 F Lauda2 C Geis3 A Weishaupt3 C Kleinschnitz3 S Rauer4 J Kuhle5 M Stangel6 F Weber7 M Uhr7 M Linnebank8 B Wildemann9 S Jarius9 M Guger10 I Ayzenberg11 A Chan11 U Zettl12 H Wiendl13 G Pilz1 W Hitzl14 JR Weber15 J Kraus1 1Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, Austria 2Department of Neurology, University Ulm, Germany 3Department of Neurology, University W{\"u}rzburg, Germany 4Department of Neurology, Albert Ludwigs University Freiburg, Germany 5Departments of Neurology and Biomedicine, University Basel, Switzerland 6Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Germany 7Research Group Inflammatory Disorders of the Central Nervous System, Max Planck Institute of Psychiatry, Germany 8Department of Neurology, University Zurich, Switzerland 9Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Germany 10Departments of Neurology and Psychiatry, AKH Linz, Austria 11Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany 12Department of Neurology, University Rostock, Germany 13Inflammatory Disorders of the Nervous System and Neurooncology, Department of Neurology, University M{\"u}nster, Germany 14Research Office, Biostatistics, Paracelsus Medical University, Austria 15Department of Neurology, Klinikum Klagenfurt, Austria ",

year = "2013",

doi = "10.1177/1352458512463483",

language = "English",

volume = "19",

pages = "1209--1212",

journal = "MULTIPLE SCLEROSIS ",

issn = "1352-4585",

number = "9",

}

Harrer, A, Tumani, H, Niendorf, S, Lauda, F, Geis, C, Weishaupt, A, Kleinschnitz, C, Rauer, S, Kuhle, J, Stangel, M, Weber, F, Uhr, M, Linnebank, M, Wildemann, B, Jarius, S, Guger, M, Ayzenberg, I, Chan, A, Zettl, U, Wiendl, H, Pilz, G , Hitzl, W, Weber, JR & Kraus, J 2013, 'Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.', MULTIPLE SCLEROSIS , vol. 19, no. 9, pp. 1209-1212. https://doi.org/10.1177/1352458512463483

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. / Harrer, Andrea (First author); Tumani, H; Niendorf, S et al.
In: MULTIPLE SCLEROSIS , Vol. 19, No. 9, 2013, p. 1209-1212.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

AU - Harrer, Andrea

AU - Tumani, H

AU - Niendorf, S

AU - Lauda, F

AU - Geis, C

AU - Weishaupt, A

AU - Kleinschnitz, C

AU - Rauer, S

AU - Kuhle, J

AU - Stangel, M

AU - Weber, F

AU - Uhr, M

AU - Linnebank, M

AU - Wildemann, B

AU - Jarius, S

AU - Guger, M

AU - Ayzenberg, I

AU - Chan, A

AU - Zettl, U

AU - Wiendl, H

AU - Pilz, Georg

AU - Hitzl, Wolfgang

AU - Weber, J R

AU - Kraus, Jörg

N1 - A Harrer1 H Tumani2 S Niendorf2 F Lauda2 C Geis3 A Weishaupt3 C Kleinschnitz3 S Rauer4 J Kuhle5 M Stangel6 F Weber7 M Uhr7 M Linnebank8 B Wildemann9 S Jarius9 M Guger10 I Ayzenberg11 A Chan11 U Zettl12 H Wiendl13 G Pilz1 W Hitzl14 JR Weber15 J Kraus1 1Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University, Austria 2Department of Neurology, University Ulm, Germany 3Department of Neurology, University Würzburg, Germany 4Department of Neurology, Albert Ludwigs University Freiburg, Germany 5Departments of Neurology and Biomedicine, University Basel, Switzerland 6Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Germany 7Research Group Inflammatory Disorders of the Central Nervous System, Max Planck Institute of Psychiatry, Germany 8Department of Neurology, University Zurich, Switzerland 9Division of Molecular Neuroimmunology, Department of Neurology, University of Heidelberg, Germany 10Departments of Neurology and Psychiatry, AKH Linz, Austria 11Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany 12Department of Neurology, University Rostock, Germany 13Inflammatory Disorders of the Nervous System and Neurooncology, Department of Neurology, University Münster, Germany 14Research Office, Biostatistics, Paracelsus Medical University, Austria 15Department of Neurology, Klinikum Klagenfurt, Austria

PY - 2013

Y1 - 2013

KW - MULTIPLE-SCLEROSIS PATIENTS

KW - NEUROLOGICAL DISEASES

KW - BLOOD

KW - CSF

U2 - 10.1177/1352458512463483

DO - 10.1177/1352458512463483

M3 - Original Article

C2 - 23093485

SN - 1352-4585

VL - 19

SP - 1209

EP - 1212

JO - MULTIPLE SCLEROSIS

JF - MULTIPLE SCLEROSIS

IS - 9

ER -

Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A et al. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. MULTIPLE SCLEROSIS . 2013;19(9):1209-1212. doi: 10.1177/1352458512463483